title: Genitourinary syndrome of the menopause--dawn of a new era?
abstract: Many millions of postmenopausal women continue to suffer in silence from symptoms resulting from estrogen-deficient atrophy of the vulva, vagina and urinary tract whilst the medical profession continues to debate what the condition should be called, how it should be assessed and whether it should be universally treated. It is high time that a unified approach was adopted by all medical societies to reach a consensus on definitions, recognition and management. With the development of the nomenclature for genitourinary syndrome of the menopause (GSM), advances in GSM assessment tools and quality-of-life questionnaires and novel therapeutic interventions, the signs are positive that a new era is finally dawning.
authors.affiliation: a Queen Charlotte's & Chelsea & Westminster Hospitals , London , UK.
authors.forename: N
authors.initials: N
authors.lastname: Panay
mesh_terms: D001284:Atrophy; D004967:Estrogens / Q000172:deficiency / Q000502:physiology; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006176:Gynecology / Q000379:methods; D006801:Humans; D054327:Lubricants; D008593:Menopause / Q000502:physiology*; D017698:Postmenopause; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013577:Syndrome; D014551:Urinary Tract / Q000473:pathology; D014621:Vagina / Q000473:pathology; D014623:Vaginal Diseases / Q000188:drug therapy; D014844:Vulva / Q000473:pathology
chemical_list: D004967:Estrogens; D054327:Lubricants
keywords: GENITOURINARY SYNDROME OF MENOPAUSE; GSM; MOST BOTHERSOME SYMPTOM; QUALITY OF LIFE; VAGINAL HEALTH INDEX; VULVA HEALTH INDEX; VULVOVAGINAL ATROPHY